VSee Health Shareholder Letter
The 2027 plan targets approximately double annual revenue as VSee concentrates on its hospital-focused iDoc business.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
VSee Health (VSEE) issued a shareholder update outlining its focus on hospital telehealth business iDoc following its Nasdaq delisting. The company previously reported expansion into 58 hospitals, and revenue from continuing operations grew in the first half of 2026 compared with the same period last year.
Its 2027 plan targets approximately double annual revenue and a path to profitability. Management expects margins to improve as contracted services activate, utilization increases and delivery costs are managed. VSee is working toward an OTCQB move and intends to seek a future Nasdaq or NYSE listing when applicable requirements are met and the board considers the timing appropriate. Management is also evaluating acquisitions, partnerships, financing alternatives and other corporate transactions.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointFirst-half 2026 revenue from continuing operations grew compared with the same period last year.
- Moderate point. Forward-looking: it has not happened yet and may not happen.2027 plan targets approximately double annual revenue and a path to profitability.
- Moderate pointHospital footprint previously expanded to 58 hospitals, providing a larger base for service deployment.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Margins are expected to improve as contracted services activate, utilization increases and delivery costs are managed.
- Minor point. Forward-looking: it has not happened yet and may not happen.iDoc growth plans focus resources on expanding hospital relationships, activating services and improving operating efficiency.
- Minor pointCorporate opportunities under evaluation include acquisitions, partnerships, financing alternatives and other transactions to support iDoc growth.
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.Nasdaq delisting has occurred; the company is working toward a move to OTCQB.
- Minor point. Forward-looking: it has not happened yet and may not happen.Future Nasdaq or NYSE listing depends on meeting applicable requirements and the board determining appropriate timing.
Key Terms
ehr technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOUSTON, TX / ACCESS Newswire / October 22, 2026 / VSee Health, Inc. (Nasdaq:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today issued the following letter from Chairman and Chief Executive Officer Dr. Imoigele Aisiku providing shareholders with an update on the Company's strategic transformation and outlook.
Dear Shareholders,
The past six months have been transformative for VSee Health. While we are all disappointed with the NASDAQ delisting , we took this opportunity to concentrate our efforts around the growth of iDoc, our hospital-focused telehealth business. That sharper focus lets our team devote its time and resources to expanding hospital relationships, activating services and building a more efficient operating company. There are some significant opportunities M&A activities that align with the company's platform and services
The progress is tangible. We previously reported our growth into 58 hospitals. We are in te initial stages Revenue from continuing operations grew in the first half of 2026 compared with the same period last year. These relationships give us a much larger base from which to build as services are deployed and utilization grows.
Our 2027 plan targets approximately double our annual revenue and a clear path to profitability. We expect margins to improve as more contracted services become active, utilization increases, delivery costs are managed and a larger revenue base, Improvement in operational efficiencies will only further drive the goal of increasing shareholder growth over the next 12 months.
We are also working to move VSee Health to the OTCQB market, an important step in improving our public market profile as we execute the operating plan. Beyond that, we intend to position the company to seek reinstatement on NASDQ or NYSE when we meet the applicable listing requirements and the board determines the timing is right. At the same time, management is actively evaluating all available avenues to maximize shareholder value, including M&A opportunities,, strategic partnerships, financing alternatives and other corporate transactions. We will assess each opportunity on its ability to support iDoc's growth and deliver value to shareholders.
Thank you for your continued support. We look forward to updating you as our team converts this opportunity into measurable results.
Sincerely,
Imo Aisiku
Chairman and Chief Executive Officer
VSee Health, Inc.
About VSee Health, Inc.
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.
For more information, please visit our website: https://www.idocvms.com
Forward-Looking Statements
This press release contains certain statements that may be deemed to be forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of VSee Health, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. More detailed information about VSee Health and the risk factors that may affect the realization of forward-looking statements is set forth in the filings with the Securities and Exchange Commission ("SEC"), including the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at www.sec.gov.
All forward-looking statements speak only as of the date on which they are made. VSee Health undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement was made, except to the extent required by applicable securities laws.
Investors Contact:
Justin Smith
jsmith@idocvms.com
SOURCE: VSee Health
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are VSee Health's revenue and profitability targets for 2027?
VSee Health's 2027 plan targets approximately double annual revenue and a path to profitability. Management expects margin improvement as more contracted services become active, utilization increases and delivery costs are managed.
What are VSee Health's listing plans after its Nasdaq delisting?
VSee Health is working to move to OTCQB and intends to position itself to seek a future Nasdaq or NYSE listing. That future listing effort depends on meeting applicable listing requirements and the board determining that the timing is appropriate.